QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Low-dose Radiotherapy Combined With Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC
- Status
- WITHDRAWN
- Phase
- PHASE1
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
- Status
- RECRUITING
- Phase
- PHASE2
Intra-arterial Chemotherapy Combined with Radiotherapy and Immunotherapy for HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Phase Ⅱ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist（Diphenhydramine）in Advanced and Metastatic Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
The Minimalist Trial-2
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- Status
- RECRUITING
- Phase
- PHASE3
PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)
- Status
- RECRUITING
- Phase
- PHASE3
Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2